Table 2.
Environmental exposure | Reference | Unit of comparison | Number of cases | Number of studies | Relative risk (95% CI) | p Value | Prediction interval | Heterogeneity (I 2 and/or p value) | Evidence class1 |
---|---|---|---|---|---|---|---|---|---|
Processed meat | WCRF, CUP 2017 | Per 50 g/day | 10,738 | 10 | 1.16 (1.08, 1.26) | 0.0002 | NA |
I
2
= 20.1%;
p = 0.258 |
III |
Red meat | WCRF, CUP 2017 | Per 100 g/day | 6,662 | 8 | 1.12 (1.00, 1.25) | 0.05 | NA |
I
2
= 23.6%;
p = 0.241 |
IV |
Light‐to‐moderate alcohol intake | WCRF, CUP 2017 | 1 drink/day | 36,942 | 8 | 1.06 (1.00, 1.11) | 0.03 | NA |
I
2
= 60.4%;
p = 0.013 |
IV |
Vegetables | WCRF, CUP 2017 | 100 g/day | 14,136 | 11 | 0.98 (0.96, 0.99) | 0.01 | NA |
I
2
= 0.0%;
p = 0.48 |
IV |
Total folate | WCRF, CUP 2017 | 100 mcg/day | 4,633 | 8 | 0.99 (0.98, 1.00) | 0.05 | NA |
I
2
= 0.0%;
p = 0.92 |
IV |
Aspirin use | Qiao Y, 2018 | Users vs. non‐users | 151,367 | 39 | 0.79 (0.74, 0.85) | 7.8×10−11 | NA |
I
2
= 91.1%; p = 0.000 |
II2 |
Aspirin and/or NSAID use | Nan H, 2015 | Regular users of aspirin, NSAIDs or both vs. non‐regular users | 8,634 | 10 | 0.69 (0.64, 0.74) | 6.20×10−28 | NA | p = 0.02 | II2 |
Use of estrogen plus progestogen therapy | Lin KJ, 2012 | Ever users vs. non‐users | NR | 17 | 0.74 (0.68, 0.81) | <0.001 | NA |
I
2
= 0%;
p = 0.88 |
III |
Overweight | WCRF, CUP 2017 | Per 5 kg/m2 increase in BMI | 71,089 (total number) | 38 (20 for men and 24 for women) | Men: 1.08 (1.04, 1.11); women: 1.05 (1.02, 1.08) |
Men: p < 0.001 Women: p < 0.001 |
NA |
Men: I
2
= 83.3%, p < 0.001; women: I 2 = 82.5%, p < 0.001 |
Men: III; Women: III |
Abbreviations: BMI, body mass index; CI, confidence interval; CUP, Continuous Update Project; G×E, gene–environment; NA, not applicable; NR, not reported; NSAID, nonsteroidal anti‐inflammatory drug; vs., versus; WCRF, World Cancer Research Fund.
Evidence class was decided using the after criteria: Convincing evidence (class I) required >1,000 cases, highly significant summary associations (p < 10−6 by random effects), a 95% prediction interval not including the null, no evidence of small‐study effects, no evidence of excess significance bias, and low heterogeneity values (I 2 < 50%). Highly suggestive evidence (class II) required >1,000 cases, highly significant summary associations (p < 10−6 by random effects), and the largest study to have a 95% confidence interval that excluded 1. Suggestive evidence (class III) required only >1,000 cases and p < 0.001 by random effects. Evidence was considered weak (class IV) when p < 0.05. No association indicates evidence for the main environmental effects with p > 0.05.
The evidence was classified as highly suggestive (class II) due to the high heterogeneity between the studies.